Celldex Therapeutics | CLDX - Equity Capital And Reserves

Stock Price
22.90
Daily Change
-1.37 -5.64%
Monthly
-12.86%
Yearly
-1.67%
Q1 Forecast
23.84

Celldex Therapeutics reported $598.36M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Celldex Therapeutics USD 598.36M 57.04M Sep/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025